Socioeconomic status and chemotherapy use for melanoma in older people

Canadian Journal on Aging

Volumn 30, Issue 1, 2011, Pages 143-153

  Reyes Ortiz, Carlos A ^a   Goodwin, James S ^b   Zhang, Dong D ^b   Freeman, Jean L ^b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

chemotherapy; melanoma; older people; socioeconomic status

Indexed keywords

ANTINEOPLASTIC AGENT;

AGE; AGED; ARTICLE; CANCER REGISTRY; CAUCASIAN; FEMALE; HEALTH DISPARITY; HUMAN; MALE; MARRIAGE; MELANOMA; MULTIVARIATE ANALYSIS; POVERTY; SKIN TUMOR; SOCIAL CLASS; UNITED STATES;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MARITAL STATUS; MELANOMA; MULTIVARIATE ANALYSIS; POVERTY AREAS; SEER PROGRAM; SKIN NEOPLASMS; SOCIAL CLASS; UNITED STATES;

EID: 79957511907     PISSN: 07149808     EISSN: 17101107     Source Type: Journal    
DOI: 10.1017/S0714980810000796     Document Type: Article

References (50)

1. American Medical Association. (1993). Physicians' current procedural terminology: CPT 94. Chicago, IL : American Medical Association .
2. Atzpodien, J., Neuber, K., Kamanabrou, D., Fluck, M., Bröcker, E.B., Neumann, C., et al. (2002). Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: Results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemo immunotherapy Group (ACIMM). British Journal of Cancer, 86 (2), 179-184. (Pubitemid 34185142)
3. Bach, P.B., Guadagnoli, E., Schrag, D., Schussler, N., & Warren, J.L. (2002). Patient demographic and socioeconomic characteristics in the SEER-Medicare database. Medical Care, 40 (Suppl. 8), IV19 - IV25 .
4. Barzilai, D.A., Koroukian, S.M., Neuhauser, D., Cooper, K.D., Rimm, A.A., & Cooper, G.S. (2004). The sensitivity of Medicare data for identifying incident cases of invasive melanoma (United States). Cancer Causes & Control, 15 (2), 179-184 . (Pubitemid 38445364)
5. Blustein, J. (1995). Medicare coverage, supplemental insurance, and the use of mammography by older women. The New England Journal of Medicine, 332 (17), 1138-1143 .
6. Charlson, M.E., Pompei, P., Ales, K.L., & MacKenzie, C.R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40 (5), 373-383 . (Pubitemid 17055592)
7. Chiarion-Sileni, V., Del Bianco, P., De Salvo, G.L., Lo Re, G., Romanini, A., Labianca, R., et al. (2003). Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. European Journal of Cancer, 39 (11), 1577-1585 . (Pubitemid 36829198)
8. Cocconi, G., Passalacqua, R., Foladore, S., Carlini, P., Acito, L., Maiello, E., et al. (2003). Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: A prospective randomized study. Melanoma Research, 13 (1), 73-79 . (Pubitemid 36269817)
9. Diez Roux, A.V., & Mair, C. (2010). Neighborhoods and health. Annals of the New York Academy of Sciences, 1186, 125-145.
10. Di Lauro, V., Scalone, S., La Mura, N., Zanetti, M., Nigri, P., Freschi, A., et al. (2005). Combined chemoimmunotherapy of metastatic melanoma: A single institution experience. Melanoma Research, 15 (3), 209-212 . (Pubitemid 40839470)
11. Du, X.L., & Goodwin, J.S. (2001a). Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer, 92 (4), 730-737 . (Pubitemid 32783056)
12. Du, X.L., & Goodwin, J.S. (2001b). Patterns of use of chemotherapy for breast cancer in older women: Findings from Medicare claims data. Journal of Clinical Oncology, 19 (5), 1455-1461 . (Pubitemid 32202553)
13. Earle, C.C., Neumann, P.J., Gelber, R.D., Weinstein, M.C., & Weeks, J.C. (2002). Impact of referral patterns on the use of chemotherapy for lung cancer. Journal of Clinical Oncology, 20 (7), 1786-1792 . (Pubitemid 34273267)
14. Eigentler, T.K., Caroli, U.M., Radny, P., & Garbe, C. (2003). Palliative therapy of disseminated malignant melanoma: A systematic review of 41 randomized clinical trials. The Lancet Oncology, 4 (12), 748-759 . (Pubitemid 37527210)
15. Eton, O., Legha, S.S., Bedikian, A.Y., Lee, J.J., Buzaid, A.C., Hodges, C., et al. (2002). Sequential biochemotherapy versus chemotherapy for metastatic melanoma: Results from a phase III randomized trial. Journal of Clinical Oncology, 20 (8), 2045-2052. (Pubitemid 34408794)
16. Falkson, C.I., Ibrahim, J., Kirkwood, J.M., Coates, A.S., Atkins, M.B., & Blum, R.H. (1998). Phase III trial of dacarbazine versus dacarbazine with interferon -2b versus dacarbazine with tamoxifen versus dacarbazine with interferon -2b and tamoxifen in patients with metastatic malignant melanoma: An Eastern Cooperative Oncology Group study. Journal of Clinical Oncology, 16 (5), 1743-1751 .
17. Freeman, J.L., Klabunde, C.N., Schussler, N., Warren, J.L., Virnig, B.A., & Cooper, G.S. (2002). Measuring breast, colorectal, and prostate cancer screening with Medicare claims data. Medical Care, 40 (Suppl. 8), IV-36-42.
18. Gorey, K.M., Holowaty, E.J., Fehringer, G., Laukkanen, E., Richter, N.L., & Meyer, C.M. (2000). An international comparison of cancer survival: Metropolitan Toronto, Ontario and Honolulu, Hawaii. American Journal of Public Health, 90, 1866-1872 .
19. Gorey, K.M., Luginaah, I.N., Bartfay, E., Fung, K.Y., Holowaty, E.J., Wright, F.C., et al. (2011). Effects of socioeconomic status on colon cancer treatment accessibility and survival in Toronto, Ontario, and San Francisco, California, 1996-2006. American Journal of Public Health. 101 (1), 112-119 .
20. Gross, C.P., Filardo, G., Mayne, S.T., & Krumholz, H.M. (2005). The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer, 103 (3), 483-491 .
21. Health Care Financing Administration. (1994). HCFA common procedure coding system (HCPCS): National level II Medicare codes. Los Angeles, CA : Practice Management Information Corporation.
22. Health Care Financing Administration. (1999). HCFA common procedure coding system (HCPCS): National level II Medicare codes. Los Angeles, CA : Practice Management Information Corporation.
23. Health Care Financing Administration. (2000). Data user reference guide (DURG). Baltimore, MD : Health Care Financing Administration .
24. Jungnelius, U., Ringborg, U., Aamdal, S., Mattsson, J., Stierner, U., Ingvar, C., et al. (1998). Dacarbazine-vindesine versus dacarbazine-vindesine- cisplatin in disseminated malignant melanoma. A randomised phase III trial. European Journal of Cancer, 34 (9), 1368-1374 . (Pubitemid 28370928)
25. Koedoot, C.G., de Haan, R.J., Stiggelbout, A.M., Stalmeier, P.F., de Graeff, A., Bakker, P.J., et al. (2003). Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice. British Journal of Cancer, 89 (12), 2219-2226 . (Pubitemid 38168003)
26. Krieger, N. (1992). Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. American Journal of Public Health, 92, 703-710 .
27. Krieger, N., Chen, J.T., Waterman, P.D., Rehkopf, D.H., & Subramanian, S.V. (2003). Race/ethnicity, gender, and monitoring socioeconomic gradients in health: A comparison of area-based socioeconomic measures - The public health disparities geocoding project. American Journal of Public Health, 93 (10), 1655-1671 . (Pubitemid 38477631)
28. Lamont, E.B., Herndon, J.E. II, Weeks, J.C., Henderson, I.C., Lifenbaum, R., Schilsky, R.L., et al. (2005). Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants. Journal of the National Cancer Institute, 97 (14), 1080-1083. (Pubitemid 41417925)
29. Luo, R., Giordano, S.H., Freeman, J.L., Zhang, D., & Goodwin, J.S. (2006). Referral to medical oncology: A crucial step in the treatment of older patients with stage III colon cancer. Oncologist, 11 (9), 1025-1033 . (Pubitemid 44564812)
30. National Cancer Institute. (1994). The SEER program code manual (revised ed.). Bethesda, MD : National Cancer Institute. NIH Publication No.94-1999
31. National Cancer Institute and the Centers for Medicare and Medicaid Services (CMS) (2007). SEER-Medicare: Brief Description of the SEER-Medicare Database. Retrieved September 02, 2007, from http://healthservices.cancer.gov/ seermedicare/overview/brief.html
32. Ostbye, T., Greenberg, G.N., Taylor, D.H., & Lee, A.M.M. (2003). Screening mammography and Pap tests among older American women 1996-2000: Results from the Health and Retirement Study (HRS) and Asset and Health Dynamics among the oldest old (AHEAD). Annals of Family Medicine, 1 (4), 209-217 .
33. Penchansky, R., & Thomas, J.W. (1981). The concept of access: Definition and relationship to consumer satisfaction. Medical Care, 19, 127-140 . (Pubitemid 11100255)
34. Polednak, A.P. (2004). Chemotherapy of non-elderly breast cancer patients by poverty-rate of area of residence in Connecticut. Breast Cancer Research and Treatment, 83 (3), 245-248 . (Pubitemid 38264872)
35. Potosky, A.L., Riley, G.F., Lubitz, J.D., Mentnech, R.M., & Kessler, L.G. (1993). Potential for cancer related health services research using a linked Medicare-tumor registry database. Medical Care, 31 (8), 732-748 .
36. Reyes-Ortiz, C.A., Goodwin, J.S., Freeman, J.L., & Kuo, Y.-F. (2006). Socioeconomic status and survival in older patients with melanoma. Journal of the American Geriatrics Society, 54 (11), 1758-1764 . (Pubitemid 44665217)
37. Reyes-Ortiz, C.A., & Markides, K.S. (2010). Socioeconomic factors, immigration status, and cancer screening among Mexican American women aged 75 and older. Health Care for Women International, 31 (12), 1068-1081 .
38. Richards, M.A., Ramirez, A.J., Degner, L.F., Fallowfield, L.J., Maher, E.J., & Neuberger, J. (1995). Offering choice of treatment to patients with cancers. European Journal of Cancer, 31A (1), 112-116 .
39. Ridolfi, R., Chiarion-Sileni, V., Guida, M., Romanini, A., Labianca, R., Freschi, A., et al. (2002). Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: Results from an Italian multicenter phase III randomized clinical trial. Journal of Clinical Oncology, 20 (6), 1600-1607 . (Pubitemid 34260541)
40. Ries L.A.G., Eisner M.P., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., et al. (Eds.). (2005). SEER cancer statistics review, 1975-2002. Bethesda, MD : National Cancer Institute. Retrieved 2006 November, from http://seer.cancer.gov/csr/1975-2002/. Based on November 2004 SEER data submission, posted to the SEER web site 2005 .
41. Romano, P.S., Roos, L.L., & Jollis, J.G. (1993). Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. Journal of Clinical Epidemiology, 46 (10), 1075-1079 .
42. Sateren, W.B., Trimble, E.L., Abrams, J., Brawley, O., Breen, N., Ford, L., et al. (2002). How sociodemographics, presence of oncology specialists and hospital cancer programs affect accrual to cancer treatment trials. Journal of Clinical Oncology, 20 (8), 2109-2117 . (Pubitemid 34408802)
43. Schrag, D., Rifas-Shiman, S., Saltz, L., Bach, P.B., & Begg, C.B. (2002). Adjuvant chemotherapy use for Medicare benefi - ciaries with stage II colon cancer. Journal of Clinical Oncology, 20 (19), 3999-4005 .
44. Shah, G.D., & Chapman, P.B. (2007). Adjuvant therapy of melanoma. Cancer Journal, 13 (3), 217-222 .
45. Stein, J.A., & Brownell, I. (2008). Treatment approaches for advanced cutaneous melanoma. Journal of Drugs in Dermatology, 7 (2), 175-179 .
46. Thirlwell, C., & Nathan, P. (2008). Melanoma part 2: Management. BMJ, 337, a2488 .
47. US Public Health Services. (1996). International classification of diseases, 9th revision. Clinical modification (5th ed.). Los Angeles, CA : Practice Management Information Corporation .
48. Verma, S., Quirt, I., McCready, D., Bak, K., Charette, M., & Iscoe, N. (2006). Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma. Cancer, 106 (7), 1431-1442 .
49. Warren, J.L., Klabunde, C.N., Schrag, D., Bach, P.B., & Riley, G.F. (2002). Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Medical Care, 40 (Suppl. 8), IV-3-18.
50. Zell, J.A., Cinar, P., Mobasher, M., Ziogas, A., Meyskens, F.L. Jr., & Anton-Culver, H. (2008). Survival for patients with invasive cutaneous melanoma among ethnic groups: The effects of socioeconomic status and treatment. Journal of Clinical Oncology, 26 (1), 66-75 .